Vienna, July 26, 2006 -- H.M. Pharma Consultancy's two most recent clinical strategy reports, "A New Paradigm for Clinical Development: The Clinical Trial in 2015" and "Microdosing in Translational Medicine: Pros and Cons" (published by Cambridge Health Advisors in November 2005 and May 2006, respectively) have received enthusiastic acceptance by the drug development community.